Analyzing SpectraScience (OTCMKTS:SCIE) and CHF Solutions (OTCMKTS:CHFS)
SpectraScience (OTCMKTS:SCIE) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.
This table compares SpectraScience and CHF Solutions’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
SpectraScience has a beta of 2.67, suggesting that its stock price is 167% more volatile than the S&P 500. Comparatively, CHF Solutions has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500.
Insider & Institutional Ownership
0.0% of SpectraScience shares are held by institutional investors. Comparatively, 10.2% of CHF Solutions shares are held by institutional investors. 0.5% of SpectraScience shares are held by company insiders. Comparatively, 3.5% of CHF Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares SpectraScience and CHF Solutions’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|CHF Solutions||$5.00 million||1.25||-$17.03 million||($42.14)||-0.07|
SpectraScience has higher earnings, but lower revenue than CHF Solutions.
This is a breakdown of recent ratings and price targets for SpectraScience and CHF Solutions, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
CHF Solutions has a consensus price target of $3.30, suggesting a potential upside of 20.00%. Given CHF Solutions’ higher possible upside, analysts plainly believe CHF Solutions is more favorable than SpectraScience.
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.
About CHF Solutions
CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Receive News & Ratings for SpectraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SpectraScience and related companies with MarketBeat.com's FREE daily email newsletter.